VERTEX PHARMACEUTICALS/ US92532F1003 /
29.04.2024 20:01:02 | Изменение -21.85 | Объем сделки | Бид3:01:04 | Предложение3:01:04 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
371.75EUR | -5.55% | 3 Оборот: 1,115.25 |
-Величина цены спроса: - | -Величина цены предложения: - | 105.98 млрдEUR | - | - |
GlobeNewswire
7:30
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration
GlobeNewswire
6:26
Stockholder Alert: Robbins LLP Informs Investors that a Class Action Against Vestis Corporation (VST...
GlobeNewswire
6:17
CANON DRIVES INTO GOLF MARKET WITH ANNOUNCEMENT OF POWERSHOT GOLF DIGITAL LASER RANGEFINDER
GlobeNewswire
5:18
LUNA Stock News: Contact Robbins LLP for Information About the Class Action Involving Luna Innovatio...
Newsfile Corp
4:49
Tradewave Capital Plc Solidifies Its Position in Financial Markets with Vienna Stock Exchange Listin...
GlobeNewswire
4:38
Stockholder Alert: Robbins LLP Informs Investors that a Class Action Against Teladoc Health, Inc. (T...
Newsfile Corp
4:19
PaleBlueDot Launches $EARTH Token: A Unique Cryptocurrency with a Mission for Global Sustainability
GlobeNewswire
3:00
Volvo Trucks North America and Volvo Financial Services Launch Volvo on Demand to Accelerate Battery...
GlobeNewswire
3:00
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf o...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница